YM BioSciences (YMI) Reports Update from Phase I/II Data From Its JAK1/JAK2 Inhibitor CYT387 at ASH 2011

Go back to YM BioSciences (YMI) Reports Update from Phase I/II Data From Its JAK1/JAK2 Inhibitor CYT387 at ASH 2011
YM BioSciences (NYSE: YMI) Delayed: 2.94 --0 (-0%)
Previous Close $2.94    52 Week High $2.95 
Open $2.94    52 Week Low $1.45 
Day High $2.94    P/E N/A 
Day Low $2.94    EPS $0.00 
Volume 6,779